Chengzhi Shareholding Co Ltd (000990) - Total Assets

Latest as of September 2025: CN¥27.52 Billion CNY ≈ $4.03 Billion USD

Based on the latest financial reports, Chengzhi Shareholding Co Ltd (000990) holds total assets worth CN¥27.52 Billion CNY (≈ $4.03 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See 000990 total equity for net asset value and shareholders' equity analysis.

Chengzhi Shareholding Co Ltd - Total Assets Trend (1997–2024)

This chart illustrates how Chengzhi Shareholding Co Ltd's total assets have evolved over time, based on quarterly financial data.

Chengzhi Shareholding Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2024)

Chengzhi Shareholding Co Ltd's total assets of CN¥27.52 Billion consist of 24.8% current assets and 75.2% non-current assets.

Asset Category Amount (CNY) % of Total Assets
Cash & Equivalents CN¥0.00 6.6%
Accounts Receivable CN¥1.29 Billion 4.8%
Inventory CN¥910.43 Million 3.4%
Property, Plant & Equipment CN¥0.00 0.0%
Intangible Assets CN¥1.01 Billion 3.7%
Goodwill CN¥6.73 Billion 24.9%

Asset Composition Trend (1997–2024)

This chart illustrates how Chengzhi Shareholding Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 000990 company net worth.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Chengzhi Shareholding Co Ltd's current assets represent 24.8% of total assets in 2024, a decrease from 50.2% in 1997.
  • Cash Position: Cash and equivalents constituted 6.6% of total assets in 2024, up from 5.0% in 1997.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 27.0% of total assets, an increase from 1.0% in 1997.
  • Asset Diversification: The largest asset category is goodwill at 24.9% of total assets.

Chengzhi Shareholding Co Ltd Competitors by Total Assets

Key competitors of Chengzhi Shareholding Co Ltd based on total assets are shown below.

Company Country Total Assets
Merus BV
NASDAQ:MRUS
USA $771.99 Million
Shanghai Allist Pharmaceuticals Co. Ltd. A
SHG:688578
China CN¥7.26 Billion
Beijing Tiantan Biological Products Corp Ltd
SHG:600161
China CN¥16.55 Billion
Beijing Hotgen Biotech Co Ltd
SHG:688068
China CN¥3.21 Billion
Savara Inc
NASDAQ:SVRA
USA $140.92 Million
Wuhan Hvsen Biotechnology Co Ltd
SHE:300871
China CN¥2.96 Billion
Wecome Pharmaceutical Co Ltd
SHE:300878
China CN¥1.49 Billion
Shanghai Shen Lian Biomedical Corp
SHG:688098
China CN¥1.56 Billion

Chengzhi Shareholding Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.46 1.30 1.10
Quick Ratio 1.28 1.16 0.94
Cash Ratio 0.00 0.00 0.00
Working Capital CN¥2.18 Billion CN¥1.60 Billion CN¥543.86 Million

Chengzhi Shareholding Co Ltd - Advanced Valuation Insights

This section examines the relationship between Chengzhi Shareholding Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 0.58
Latest Market Cap to Assets Ratio 0.07
Asset Growth Rate (YoY) 5.2%
Total Assets CN¥27.08 Billion
Market Capitalization $2.00 Billion USD

Valuation Analysis

Below Book Valuation: The market values Chengzhi Shareholding Co Ltd's assets below their book value (0.07x), which may indicate investor concerns about asset quality or future growth.

Positive Asset Growth: Chengzhi Shareholding Co Ltd's assets grew by 5.2% over the past year, showing continued investment in the company's operational capacity.

Annual Total Assets for Chengzhi Shareholding Co Ltd (1997–2024)

The table below shows the annual total assets of Chengzhi Shareholding Co Ltd from 1997 to 2024.

Year Total Assets Change
2024-12-31 CN¥27.08 Billion
≈ $3.96 Billion
+5.19%
2023-12-31 CN¥25.74 Billion
≈ $3.77 Billion
+4.96%
2022-12-31 CN¥24.53 Billion
≈ $3.59 Billion
+0.32%
2021-12-31 CN¥24.45 Billion
≈ $3.58 Billion
+0.14%
2020-12-31 CN¥24.41 Billion
≈ $3.57 Billion
+1.48%
2019-12-31 CN¥24.06 Billion
≈ $3.52 Billion
+2.88%
2018-12-31 CN¥23.38 Billion
≈ $3.42 Billion
+11.23%
2017-12-31 CN¥21.02 Billion
≈ $3.08 Billion
+4.32%
2016-12-31 CN¥20.15 Billion
≈ $2.95 Billion
+308.86%
2015-12-31 CN¥4.93 Billion
≈ $721.17 Million
+25.70%
2014-12-31 CN¥3.92 Billion
≈ $573.75 Million
+17.74%
2013-12-31 CN¥3.33 Billion
≈ $487.29 Million
+9.77%
2012-12-31 CN¥3.03 Billion
≈ $443.90 Million
-9.46%
2011-12-31 CN¥3.35 Billion
≈ $490.30 Million
-5.52%
2010-12-31 CN¥3.55 Billion
≈ $518.94 Million
-4.03%
2009-12-31 CN¥3.70 Billion
≈ $540.71 Million
+29.64%
2008-12-31 CN¥2.85 Billion
≈ $417.08 Million
+26.00%
2007-12-31 CN¥2.26 Billion
≈ $331.01 Million
+1.52%
2006-12-31 CN¥2.23 Billion
≈ $326.06 Million
+16.54%
2005-12-31 CN¥1.91 Billion
≈ $279.78 Million
+14.36%
2004-12-31 CN¥1.67 Billion
≈ $244.65 Million
+4.99%
2003-12-31 CN¥1.59 Billion
≈ $233.03 Million
+12.92%
2002-12-31 CN¥1.41 Billion
≈ $206.36 Million
+52.92%
2001-12-31 CN¥922.18 Million
≈ $134.94 Million
+17.29%
2000-12-31 CN¥786.22 Million
≈ $115.05 Million
+192.59%
1999-12-31 CN¥268.71 Million
≈ $39.32 Million
+25.55%
1998-12-31 CN¥214.03 Million
≈ $31.32 Million
+43.76%
1997-12-31 CN¥148.87 Million
≈ $21.78 Million
--

About Chengzhi Shareholding Co Ltd

SHE:000990 China Biotechnology
Market Cap
$2.00 Billion
CN¥13.68 Billion CNY
Market Cap Rank
#6334 Global
#1437 in China
Share Price
CN¥11.26
Change (1 day)
-1.92%
52-Week Range
CN¥7.24 - CN¥13.17
All Time High
CN¥30.90
About

Chengzhi Co., Ltd. engages in the clean energy, semiconductor display material, medical healthcare, and life science businesses in China. The company produces and sells gas products, including carbon monoxide, syngas, butane, isobutanal, ethane, propane, crude benzene, ethylene, hydrogen, propylene, methanol, butylene glycol, Butanoctyl, diolefin, and other chemicals. It also produces and sells l… Read more